AC
ADMA icon

AXQ Capital’s ADMA Biologics ADMA Stock Holding History

AXQ Capital’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$557K Buy
61,789
+42,148
+215% +$665K 0.07% 385
2025
Q4 		$358K Sell
19,641
-78
-0.4% -$1.31K 0.08% 380
2025
Q3 		$289K Buy
+19,719
New +$338K 0.11% 326
2024
Q2 		– Sell
-19,800
Closed -$131K – 431
2024
Q1 		$131K Buy
+19,800
New +$108K 0.03% 561

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

AXQ Capital's ADMA Position: Q1 2026 in Review

AXQ Capital increased its ADMA Biologics (ADMA) stake by 215% in Q1 2026, buying an estimated $665K and bringing the position to 61,789 shares worth $557K. The position accounts for 0.07% of the portfolio, ranked #385.

AXQ Capital first reported a position in ADMA in Q1 2024 and has held it in 4 quarters since. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • AXQ Capital held 61,789 shares of ADMA Biologics worth $557K as of Q1 2026.
  • AXQ Capital bought 42,148 ADMA Biologics shares in Q1 2026, an estimated $665K.
  • ADMA Biologics made up 0.07% of AXQ Capital's portfolio in Q1 2026, its #385 holding.
  • AXQ Capital first reported a position in ADMA Biologics in Q1 2024 and has held it in 4 quarters since.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.